栄研化学の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/02/08 | 1,930 | 1,957 | 1,915 | 1,939 | ±0 | ±0% | 123,900 |
| 2024/02/07 | 1,950 | 1,960 | 1,922 | 1,939 | -6 | -0.3% | 175,900 |
| 2024/02/06 | 1,947 | 1,959 | 1,907 | 1,945 | -6 | -0.3% | 295,600 |
| 2024/02/05 | 1,966 | 1,966 | 1,929 | 1,951 | -24 | -1.2% | 216,500 |
| 2024/02/02 | 1,942 | 1,987 | 1,933 | 1,975 | +32 | +1.6% | 279,900 |
| 2024/02/01 | 1,835 | 1,963 | 1,824 | 1,943 | +100 | +5.4% | 515,200 |
| 2024/01/31 | 1,850 | 1,914 | 1,828 | 1,843 | +104 | +6% | 450,900 |
| 2024/01/30 | 1,781 | 1,792 | 1,729 | 1,739 | -39 | -2.2% | 124,300 |
| 2024/01/29 | 1,768 | 1,784 | 1,765 | 1,778 | +10 | +0.6% | 113,000 |
| 2024/01/26 | 1,760 | 1,788 | 1,757 | 1,768 | +13 | +0.7% | 146,300 |
| 2024/01/25 | 1,741 | 1,757 | 1,736 | 1,755 | +18 | +1% | 117,300 |
| 2024/01/24 | 1,740 | 1,747 | 1,731 | 1,737 | -23 | -1.3% | 89,900 |
| 2024/01/23 | 1,770 | 1,787 | 1,756 | 1,760 | -13 | -0.7% | 98,400 |
| 2024/01/22 | 1,758 | 1,779 | 1,758 | 1,773 | +15 | +0.9% | 78,000 |
| 2024/01/19 | 1,760 | 1,769 | 1,736 | 1,758 | +6 | +0.3% | 139,800 |
| 2024/01/18 | 1,734 | 1,759 | 1,729 | 1,752 | +15 | +0.9% | 93,200 |
| 2024/01/17 | 1,820 | 1,838 | 1,735 | 1,737 | -80 | -4.4% | 289,100 |
| 2024/01/16 | 1,835 | 1,849 | 1,813 | 1,817 | -3 | -0.2% | 280,300 |
| 2024/01/15 | 1,802 | 1,823 | 1,790 | 1,820 | +32 | +1.8% | 183,300 |
| 2024/01/12 | 1,738 | 1,798 | 1,715 | 1,788 | +59 | +3.4% | 270,800 |
| 2024/01/11 | 1,735 | 1,742 | 1,706 | 1,729 | +4 | +0.2% | 103,500 |
| 2024/01/10 | 1,705 | 1,741 | 1,700 | 1,725 | +25 | +1.5% | 145,000 |
| 2024/01/09 | 1,704 | 1,720 | 1,699 | 1,700 | -10 | -0.6% | 123,400 |
| 2024/01/05 | 1,713 | 1,720 | 1,694 | 1,710 | +3 | +0.2% | 148,700 |
| 2024/01/04 | 1,701 | 1,709 | 1,678 | 1,707 | -2 | -0.1% | 69,700 |
| 2023/12/29 | 1,718 | 1,726 | 1,697 | 1,709 | -9 | -0.5% | 103,300 |
| 2023/12/28 | 1,696 | 1,718 | 1,693 | 1,718 | +11 | +0.6% | 198,300 |
| 2023/12/27 | 1,700 | 1,709 | 1,695 | 1,707 | +4 | +0.2% | 80,900 |
| 2023/12/26 | 1,700 | 1,707 | 1,691 | 1,703 | +5 | +0.3% | 97,400 |
| 2023/12/25 | 1,722 | 1,723 | 1,692 | 1,698 | -21 | -1.2% | 67,900 |
| 2023/12/22 | 1,701 | 1,721 | 1,701 | 1,719 | +8 | +0.5% | 72,500 |
| 2023/12/21 | 1,706 | 1,718 | 1,701 | 1,711 | -2 | -0.1% | 82,300 |
| 2023/12/20 | 1,718 | 1,728 | 1,705 | 1,713 | +2 | +0.1% | 95,900 |
| 2023/12/19 | 1,707 | 1,718 | 1,693 | 1,711 | -2 | -0.1% | 127,700 |
| 2023/12/18 | 1,689 | 1,722 | 1,681 | 1,713 | +8 | +0.5% | 108,200 |
| 2023/12/15 | 1,734 | 1,735 | 1,698 | 1,705 | -22 | -1.3% | 160,300 |
| 2023/12/14 | 1,729 | 1,736 | 1,703 | 1,727 | -1 | -0.1% | 137,700 |
| 2023/12/13 | 1,724 | 1,740 | 1,707 | 1,728 | +21 | +1.2% | 168,200 |
| 2023/12/12 | 1,730 | 1,733 | 1,691 | 1,707 | -18 | -1% | 169,600 |
| 2023/12/11 | 1,748 | 1,748 | 1,714 | 1,725 | -3 | -0.2% | 135,500 |
| 2023/12/08 | 1,764 | 1,764 | 1,714 | 1,728 | -23 | -1.3% | 175,600 |
| 2023/12/07 | 1,749 | 1,768 | 1,743 | 1,751 | -13 | -0.7% | 119,600 |
| 2023/12/06 | 1,718 | 1,764 | 1,713 | 1,764 | +73 | +4.3% | 251,000 |
| 2023/12/05 | 1,694 | 1,704 | 1,683 | 1,691 | -10 | -0.6% | 117,800 |
| 2023/12/04 | 1,675 | 1,704 | 1,661 | 1,701 | +6 | +0.4% | 147,000 |
| 2023/12/01 | 1,680 | 1,714 | 1,680 | 1,695 | +48 | +2.9% | 283,600 |
| 2023/11/30 | 1,640 | 1,650 | 1,632 | 1,647 | -8 | -0.5% | 127,900 |
| 2023/11/29 | 1,638 | 1,664 | 1,638 | 1,655 | +11 | +0.7% | 131,500 |
| 2023/11/28 | 1,669 | 1,669 | 1,612 | 1,644 | -27 | -1.6% | 259,000 |
| 2023/11/27 | 1,665 | 1,696 | 1,665 | 1,671 | +6 | +0.4% | 195,900 |
301～
350
件表示中 / 6946件
類似銘柄と比較する
現在ご覧いただいている「栄研化」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 栄研化 | 222,200円 | +0.4% | -8.4% | 2.39% | 28.52倍 | 1.61倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
| 持田薬 | 309,000円 | +3.0% | +27.5% | 2.59% | 19.56倍 | 0.85倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| 杏林製薬 | 148,600円 | +8.8% | +99.9% | 3.50% | 9.49倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| ネクセラファーマ | 93,400円 | +22.8% | - | 0.00% | 76.31倍 | 1.23倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| あすかＨＤ | 229,600円 | +0.3% | +2.7% | 2.18% | 13.02倍 | 1.01倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。２１年春にあすか製薬が持株会社化 |
市場注目の銘柄
チャート関連のコラム
